Alexion Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch ALXN and buy or sell other stocks, ETFs, and their options commission-free!

About ALXN

Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology.

CEO

Marc Pierre Jean Dunoyer, MBA

CEOMarc Pierre Jean Dunoyer, MBA

Employees

—

Employees—

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1992

Founded1992

Employees

—

Employees—

ALXN Key Statistics

Market cap

40.34B

Market cap40.34B

Price-Earnings ratio

59.70

Price-Earnings ratio59.70

Dividend yield

—

Dividend yield—

Average volume

14.86M

Average volume14.86M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$187.45

52 Week high$187.45

52 Week low

$99.91

52 Week low$99.91

People also own

Based on the portfolios of people who own ALXN. This list is generated using Robinhood data, and it’s not a recommendation.